<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>) is common in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:chebi fb="20" ids="15767">DCM</z:chebi>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> may alter cardiac substrate supply and utilisation leading to changes in myocardial metabolism and cardiac function </plain></SENT>
<SENT sid="2" pm="."><plain>In rats, exposure to excessive alimentary fat, inducing a type 2 diabetic phenotype, may result in myocardial <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and cardiac functional changes resembling <z:chebi fb="20" ids="15767">DCM</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Rats received high-fat (HFD) or low-fat (LFD) diets for 7 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>Prior to killing, insulin or saline was injected i.p </plain></SENT>
<SENT sid="5" pm="."><plain>Contractile function and insulin signalling were assessed in papillary muscles and ventricular lysates, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Fasting and post-load blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were increased in HFD- vs LFD-rats (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.02) </plain></SENT>
<SENT sid="7" pm="."><plain>Mean heart weight, but not body weight, was increased in HFD-rats (p &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>HFD-hearts showed structural changes and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> accumulation </plain></SENT>
<SENT sid="9" pm="."><plain>HFD-muscles developed higher baseline and maximum forces, but showed impaired recovery from higher workloads </plain></SENT>
<SENT sid="10" pm="."><plain>Insulin-associated modulation of <z:chebi fb="0" ids="29108">Ca2+</z:chebi>-induced force augmentation was abolished in HFD-muscles </plain></SENT>
<SENT sid="11" pm="."><plain>HFD reduced insulin-stimulated IRS1-associated phosphatidylinositol 3'-kinase activity and phosphorylation of protein kinase B, <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3beta, endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, and forkhead transcription factors by 40-60% (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>Insulin-mediated phosphorylation of phospholamban, a critical regulator of myocardial contractility, was decreased in HFD-hearts (p &lt; 0.05) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS/INTERPRETATION: HFD induced a <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>-like cardiac phenotype, characterised by a higher basal contractile force, an impaired recovery from increased workloads and decreased insulin-mediated protection against <z:chebi fb="0" ids="29108">Ca2+</z:chebi> overload </plain></SENT>
<SENT sid="14" pm="."><plain>Cardiac dysfunction was associated with myocardial <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and phospholamban hypophosphorylation </plain></SENT>
<SENT sid="15" pm="."><plain>Our data suggest that myocardial <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, resulting from exposure to excessive alimentary fat, may contribute to the pathogenesis of <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
</text></document>